iGii will be at MEDICA 2026 to meet companies developing diagnostic and sensing products and to explore where Gii could support their next stage of development.
Gii is iGii’s proprietary 3D porous carbon nanomaterial. It provides a high electrochemically active surface area, inherent antifouling behaviour and a platform designed with repeatable, scalable manufacture in mind.
Why meet us?
A strong assay result is only one part of creating a successful diagnostic product. Material performance, electrode design, sample behaviour, integration, manufacturing and the route to supply all influence whether a technology can move beyond the laboratory.
At MEDICA, we would particularly like to meet teams working on:
- Electrochemical and point-of-care diagnostics
- Complex biological or environmental sample matrices
- Multi-analyte sensing
- Enzymatic and affinity-based assays
- Custom electrode and microfluidic integration
- Translation from feasibility into a scalable product platform
Who will be there?
- Dr Jo Holmes, Sales Director, and Dr James Youell, Sales Director will attend throughout MEDICA from Monday 16 to Thursday 19 November.
- Dr Marco Caffio, co-founder and Chief Scientific Officer, and Dr Pablo Lozano Sanchez, Head of R&D will join them from Monday 16 to Wednesday 18 November.
- Jean-Christophe Granier, Chief Executive Officer will attend on Wednesday 18 and Thursday 19 November.
Book a meeting
If you have an active development programme, existing assay chemistry or a product challenge where the sensing material may be limiting performance or integration, tell us a little about it. We will make sure you meet the right member of the iGii team.